Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Asker Healthcare Group ABOSTO:ASKER -7.71%13 5-Year Yield-on-Cost % is 0.46 as of Jul. 22, 2026, which is 4% below its 10-year median of 0.48. GuruFocus rates OSTO:ASKER with a GF Score™ of 13/100. The stock has 2 warning signs investors should review. Among 69 Medical Distribution companies, Asker Healthcare Group AB ranks worse than 92.75% on this metric.
The historical rank and industry rank for Asker Healthcare Group AB's 5-Year Yield-on-Cost % or its related term are showing as below:
OSTO:ASKER'
s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.46 Med: 0.48 Max: 0.5
Current: 0.46
During the past 4 years, Asker Healthcare Group AB's highest Yield on Cost was 0.50. The lowest was 0.46. And the median was 0.48.
OSTO:ASKER's 5-Year Yield-on-Cost % is ranked worse than 92.75% of 69
companies
in the Medical Distribution industry
Industry Median: 3.66
vs OSTO:ASKER: 0.46
Asker Healthcare Group AB (OSTO:ASKER) 5-Year Yield-on-Cost % Explanation
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
Asker Healthcare Group AB 5-Year Yield-on-Cost % Related Terms
OSTO:ASKER vs MCK, CAH, COR: 5-Year Yield-on-Cost % Comparison
For the Medical Distribution subindustry, Asker Healthcare Group AB's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Asker Healthcare Group AB 5-Year Yield-on-Cost % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Asker Healthcare Group AB's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where Asker Healthcare Group AB's 5-Year Yield-on-Cost % falls into.
Asker Healthcare Group AB 5-Year Yield-on-Cost % Calculation
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Asker Healthcare Group AB (OSTO:ASKER) has a 5-Year Yield-on-Cost % of 0.46 as of Jul. 22, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Asker Healthcare Group AB and its competitors. This is near median its historical median of 0.48. Over the past decade, Asker Healthcare Group AB's 5-Year Yield-on-Cost % has ranged from 0.46 to 0.50. According to the industry distribution chart, Asker Healthcare Group AB ranks #64 out of 69 companies in the Medical Distribution industry, placing it in the top 92.8%.
Is Asker Healthcare Group AB's 5-Year Yield-on-Cost % too high?
Asker Healthcare Group AB's current 5-Year Yield-on-Cost % of 0.46 is near median its 10-year median of 0.48. Over the past 10 years, this metric has ranged from a low of 0.46 to a high of 0.50. The Medical Distribution industry median 5-Year Yield-on-Cost % is 3.66. Asker Healthcare Group AB's value of 0.46 is 87.4% below this industry median. Based on the distribution chart, Asker Healthcare Group AB ranks #64 out of 69 companies in the Medical Distribution industry, which is in the bottom quartile relative to peers. Overall, Asker Healthcare Group AB has a GF Score™ of 13/100, reflecting its overall financial health beyond just this single metric.
How does Asker Healthcare Group AB's 5-Year Yield-on-Cost % compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, Asker Healthcare Group AB ranks #64 out of 69 companies for 5-Year Yield-on-Cost %. This places Asker Healthcare Group AB in the lower half of its industry. The industry median 5-Year Yield-on-Cost % is 3.66. Asker Healthcare Group AB's value of 0.46 is 87.4% below this benchmark. Historically, Asker Healthcare Group AB's own 5-Year Yield-on-Cost % has ranged from 0.46 to 0.50 over the past decade. While the company's 10-year median is 0.48 vs. the industry median of 3.66, Asker Healthcare Group AB has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Medical Distribution company?
The median 5-Year Yield-on-Cost % among Medical Distribution companies is 3.66, based on 69 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Asker Healthcare Group AB's current 5-Year Yield-on-Cost % of 0.46 is 87.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Asker Healthcare Group AB and its competitors. For the Medical Distribution industry, the median 5-Year Yield-on-Cost % is 3.66 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Asker Healthcare Group AB's current 5-Year Yield-on-Cost % is 0.46, which is near median its own 10-year median of 0.48. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Asker Healthcare Group AB stock overvalued right now?
Asker Healthcare Group AB (OSTO:ASKER) has a current 5-Year Yield-on-Cost % of 0.46. The current 5-Year Yield-on-Cost % is 0.46, which is near median its 10-year median of 0.48 and 87.4% below the Medical Distribution industry median of 3.66. Asker Healthcare Group AB's overall GF Score™ is 13/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Asker Healthcare Group AB (OSTO:ASKER), the current 5-Year Yield-on-Cost % is 0.46 as of Jul. 22, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Asker Healthcare Group AB is a provider of medical products and solutions that drive progress in the European healthcare sector. The company is engaged in building and acquiring companies to support the healthcare system to improve patient outcomes, reduce the total cost of care, and ensure a fair and sustainable value chain. The company also offers a range of value-added solutions to support its suppliers and customers in, for example, market access, efficiency, and sustainability. Company has adapted a twin engine growth strategy that combines organic and acquired growth. Geographically, the company evaluates the operations in three business areas: North, West and Central.
13GF Score
Get the complete analysis for OSTO:ASKER
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSTO:ASKER has been successfully added to your 
